| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 12/11/2024 | 23:31 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] | NASDAQ:NTRP | NextTrip Inc |
| 12/11/2024 | 22:42 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NTRP | NextTrip Inc |
| 15/10/2024 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:NTRP | NextTrip Inc |
| 31/05/2024 | 22:25 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | NASDAQ:NTRP | NextTrip Inc |
| 04/02/2021 | 15:00 | PR Newswire (US) | Synthetic Bryostatin Available to Expand Neurodegenerative Indication Trials | NASDAQ:NTRP | NextTrip Inc |
| 02/12/2020 | 15:00 | PR Newswire (US) | Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals | NASDAQ:NTRP | NextTrip Inc |
| 02/12/2020 | 14:19 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:NTRP | NextTrip Inc |
| 27/11/2020 | 23:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:NTRP | NextTrip Inc |
| 25/11/2020 | 23:15 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:NTRP | NextTrip Inc |
| 24/11/2020 | 19:47 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:NTRP | NextTrip Inc |
| 20/11/2020 | 15:00 | PR Newswire (US) | Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates | NASDAQ:NTRP | NextTrip Inc |
| 09/11/2020 | 23:02 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:NTRP | NextTrip Inc |
| 02/11/2020 | 23:20 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:NTRP | NextTrip Inc |
| 06/10/2020 | 15:00 | PR Newswire (US) | Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of Bryostatin in Alzheimer's Disease | NASDAQ:NTRP | NextTrip Inc |
| 30/09/2020 | 15:28 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:NTRP | NextTrip Inc |
| 30/09/2020 | 15:15 | PR Newswire (US) | Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with Metuchen | NASDAQ:NTRP | NextTrip Inc |
| 30/07/2020 | 15:00 | PR Newswire (US) | Neurotrope Bioscience Announces Agreement with Worldwide Clinical Trials, to Conduct Ongoing Phase 2 Study of Bryostatin-1, P... | NASDAQ:NTRP | NextTrip Inc |
| 10/06/2020 | 14:41 | PR Newswire (US) | Neurotrope Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the Nation... | NASDAQ:NTRP | NextTrip Inc |
| 28/05/2020 | 15:00 | PR Newswire (US) | Neurotrope Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Pa... | NASDAQ:NTRP | NextTrip Inc |
| 26/05/2020 | 22:20 | PR Newswire (US) | Neurotrope Announces Investor Update Conference Call | NASDAQ:NTRP | NextTrip Inc |
| 18/05/2020 | 14:45 | PR Newswire (US) | Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company | NASDAQ:NTRP | NextTrip Inc |
| 27/04/2020 | 12:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:NTRP | NextTrip Inc |
| 24/04/2020 | 23:17 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) | NASDAQ:NTRP | NextTrip Inc |
| 17/04/2020 | 23:20 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:NTRP | NextTrip Inc |
| 13/03/2020 | 22:05 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:NTRP | NextTrip Inc |
| 14/02/2020 | 16:34 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:NTRP | NextTrip Inc |
| 03/02/2020 | 23:15 | GlobeNewswire Inc. | XpresSpa Appoints Robert Weinstein to Board of Directors | NASDAQ:NTRP | NextTrip Inc |
| 31/01/2020 | 12:08 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:NTRP | NextTrip Inc |
| 23/01/2020 | 15:31 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:NTRP | NextTrip Inc |
| 22/01/2020 | 20:05 | PR Newswire (US) | Neurotrope, Inc. Announces $18 Million Registered Direct Offering | NASDAQ:NTRP | NextTrip Inc |